Contract award
XEQUEL BIO, INC.
GRANEXIN AS A TOPICAL THERAPEUTIC TO MITIGATE CUTANEOUS RADIATION INJURY
- PIID
- 75N93021C00009
- Award key
- CONT_AWD_75N93021C00009_7529_-NONE-_-NONE-
- Recipient UEI
- T4JKC8B27PJ7
- Source as of
- —
Current award value
$6,618,8863
Obligated to date
$6,618,8862
Potential with options
$6,618,8863
- Awarding agency
- Department of Health and Human ServicesNational Institutes of Health
- Contractor
- XEQUEL BIO, INC.
- Place of performance
- Mount Pleasant, South Carolina
- Set-aside
- No set-aside used
- Pricing
- Cost Plus Fixed Fee
- Competition
- Full and Open Competition5 offers received
- Period of performance
- Mar 16, 2021 — Feb 28, 2025Through Feb 28, 2025 if all options are exercised
- Benchmark category
- Unclassified
Transaction history
Every action recorded against this award, in the order the government reported them.
| Mod | Action date | Reason | Obligation | Value at action |
|---|---|---|---|---|
| 0 | Mar 15, 2021 | Initial award | $1,693,749.00 | $6,618,886.46 |
| P00001 | Jun 8, 2021 | M | $0.00 | $6,618,886.46 |
| P00002 | Oct 15, 2021 | M | $0.00 | $6,618,886.46 |
| P00003 | Mar 4, 2022 | G | $1,650,013.00 | $6,618,886.46 |
| P00004 | Sep 16, 2022 | V | $1,007,117.00 | $6,618,886.46 |
| P00005 | Sep 16, 2022 | M | $0.00 | $6,618,886.46 |
| P00006 | Mar 8, 2023 | G | $1,631,855.00 | $6,618,886.46 |
| P00007 | Sep 12, 2023 | C | $500,000.00 | $6,618,886.46 |
| P00008 | Dec 22, 2023 | M | $0.00 | $6,618,886.46 |
| P00009 | Sep 20, 2024 | M | $137,994.00 | $6,618,886.46 |
| P00010 | Oct 30, 2024 | M | $0.00 | $6,618,886.46 |
| P00011 | Aug 20, 2026 | C | -$1,841.54 | $6,618,886.46 |
Provenance
Which source record produced each displayed rollup figure.
| Field | Source | File | Retrieved | Parser | Artifact hash |
|---|---|---|---|---|---|
| awarding_agency_id | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
| contractor_id | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
| current_award_value | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
| naics_code | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
| potential_award_value | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
| psc_code | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
| total_obligated | USAspending.gov | — | Aug 22, 2026 | usaspending_contract_csv@2026.08.2 | 68271caf7dc1 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.
- 1Rollup values derive from 12 transaction records parsed from USAspending.gov, retrieved Aug 22, 2026 by transform awards@2026.08.1.
- 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
- 3Current and potential award values are taken from the latest reported action, not summed across modifications.